Mass Spectrometry Facility – Services
Small Molecule Characterization/Validation
High-resolution mass spectrometry can be used to determine the molecular formula of new chemical entities. When synthesizing compounds or characterizing natural products, metabolites or other new compounds a high-resolution, accurate mass spectrum can be used to determine the compound’s chemical formula. High-resolution mass spectrometry and NMR are key steps in publishing new chemical structures. At the AIC MS-Facility we have two, high-resolution mass spectrometers, a Bruker MaXis time-of-flight spectrometer and a Thermo Q-Exactive Orbitrap spectrometer. Both of these instruments are capable of mass measurements with sub-ppm mass accuracy and broadband resolution (FWHM) >60,000. This is sufficient for assigning formulae for most compounds up to ~500 Da. These spectrometers are also capable of MS/MS for structural analysis for further structural validations.
Small Molecule Quantitation
Internal Server Error
The server encountered an internal error and was unable to complete your request. Either the server is overloaded or there is an error in the application.
Protein/Large Molecule Characterization & Validation
Mass spectrometry can also be used to characterize larger molecules. High-resolution MS can be used to interrogate intact proteins and other large molecules, so-called “Top-Down” MS. In the AIC the Bruker MaXis time-of-flight spectrometer can be used to look at purified proteins in the mass range of 65,000 Da. This will tell us if the theoretical and observed masses match. Differences from the theoretical can indicate different types of modifications. Exact locations of modifications can frequently be elucidated by digesting proteins with trypsin and using liquid chromatography-tandem MS (isolation and fragmentation of a peptide then measuring the mass of the fragments). This LC/MS/MS can also be used to identify unknown proteins that researchers may find in co-immunopreciptations or other experiments. We recently used LC/MS/MS to validate the identity of overexpressed, recombinant proteins that were being used in clinical vaccine trials for a client of the Waisman Biomanufacturing Facility.
It is often important to understand how cells or organisms respond to drugs, or environmental changes. Frequently the complement of cellular proteins will change in response to these perturbations. Understanding these changes can provide insight into the mechanistic details of the response. In the AIC-MS Facility we can use relative proteomic quantitation by liquid chromatography-tandem mass spectrometry (LC/MS/MS) to evaluate global changes in response to drugs or other treatments. We prepare protein extracts from treated and untreated conditions, digest the proteins with trypsin and run replicate LC/MS/MS analysis on our nAcquity/Q-Exactive. We then use the SIEVE software package to identify peptides observed in the run, and perform a statistical comparison of the area-under-the-curve. An extracted ion chromatogram of each observed peptide is constructed and the relative areas in treated and control samples are compared. Ultimately this analysis provides a list of identified proteins and their relative fold-changes in the two (or more) conditions. These lists of identified proteins with their regulatory changes can then be further analyzed for common enzymatic or regulatory pathways.